ProcuraAxisBeta
Sign inCreate Free Account
Home / Opportunities / Opportunity
PROCUREMENT OPPORTUNITY

NHS Genomic Medicine Service - Most Suitable Provider Process

NHS England · compiled

Tender information last checkedLast checked 30 Sept 2026, 06:36.

Opportunity overview

This is a notice of intention to make an award in respect of the NHS Genomic Medicine Service pursuant to the Most Suitable Provider (MSP) Process for the NHS Genomic Medicine Service (NHS GMS). For the avoidance of doubt, this is an intention to award notice. A notice of the confirmation of the award of each contract will be issued once they are signed.<br/><br/>Pursuant to the NHS GMS contracts, provider are to provide the following functions: <br/>• Organisational leadership, governance and partnership arrangements;<br/>• Delivery of genomic testing outlined in the National Genomic Test Directory (NGTD);<br/>• Laboratory operating model;<br/>• Clinical function: cancer genomics;<br/>• Clinical function: rare disease;<br/>• Clinical function: population health;<br/>• Promotion of and supporting and leading where relevant science, research and / or innovation;<br/>• Transformation and Service Improvement;<br/>• People – workforce, education and training; and<br/>• Data and digital

Awarded to

Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.

North Bristol NHS Trust

No match
Contract value
£5.2bn
Awarded
Not supplied
Contract signed
20 Oct 2025
Award ID
067976-2025-5
Status
active
Location
Bristol, UKK1, United Kingdom

Classification

  • CPV85100000 — Health services

Lots

  • Lot 1 – NHS North-West GMSValue not stated
  • Lot 2 – NHS North-East and Yorkshire GMSValue not stated
  • Lot 3 – NHS Central and South GMSValue not stated
  • Lot 4 – NHS East GMSValue not stated
  • Lot 5 – NHS South-West GMSValue not stated
  • Lot 6 – NHS North Thames GMSValue not stated
  • Lot 7 – NHS South-East GMSValue not stated

Published notice details

Additional information from the published procurement release. Fields appear only when supplied by the source; check the original notice and tender documents before acting.

Scope, procedure and submissions

Id
C368833
Status
complete
Procurement Method
limited
Main Procurement Category
services
Procurement Method Details
Award procedure without prior publication of a call for competition
Why this procedure was chosen
This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act Regulations 2023 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to decision makers by Tuesday 4th November 2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.

Legal basis

Id
32014L0024
Scheme
CELEX

Communication

Future Notice Date
18 Sept 2025, 00:00

Classification

Id
85100000
Scheme
CPV
Description
Health services

Procedure reasons

Entry 1
Id
D_OUTSIDE_SCOPE
Scheme
TED_PT_AWARD_CONTRACT_WITHOUT_CALL
Description
The procurement falls outside the scope of application of the directive

Lots and requirements

Entry 1
Id
1
Title
Lot 1 – NHS North-West GMS
Status
cancelled
Has Options
Yes
Description
Pursuant to the NHS GMS contracts, providers are to provide the following functions:<br/>* Organisational leadership, governance and partnership arrangements;<br/>* Delivery of genomic testing outlined in the National Genomic Test Directory (NGTD);<br/>* Laboratory operating model;<br/>* Clinical function: cancer genomics;<br/>* Clinical function: rare disease;<br/>* Clinical function: population health;<br/>* Promotion of and supporting and leading where relevant science, research and / or innovation;<br/>* Transformation and Service Improvement;<br/>* People – workforce, education and training; and<br/>* Data and digital<br/>The Commissioner intends to award contracts following the Most Suitable Process to 7 providers which are existing providers. This is an expansion of existing services which, under PSR, constitutes a new service.<br/>The approximate lifetime value of the contract for all Lots is £5,175,000,000.<br/>The services will start on 1st April 2026 and the initial period will run until 31st March 3034 with an option to extend for up to a further 2 years (of 2 x 12 month periods).<br/>Please note that the figure included in the 'Awarded Value' section of this part of the notice is the total approximate lifetime value of all Lots of the NHS Genomic Medicine Service contract. For the avoidance of doubt, this is not the approximate lifetime value for each Lot. The approximate lifetime value for each Lot shall be included within the confirmation of contract award notice (which shall be issued once contracts have been signed).

Options

Description
Options to extend for up to a further 2 years (of 2 x 12 month periods) following the initial 8 year contract period.

Award criteria

Criteria

Criterion 1
Name
Most suitable provider process with regard to the key Criteria
Type
cost
Description
100
Entry 2
Id
2
Title
Lot 2 – NHS North-East and Yorkshire GMS
Status
cancelled
Has Options
Yes
Description
Pursuant to the NHS GMS contracts, providers are to provide the following functions:<br/>* Organisational leadership, governance and partnership arrangements;<br/>* Delivery of genomic testing outlined in the National Genomic Test Directory (NGTD);<br/>* Laboratory operating model;<br/>* Clinical function: cancer genomics;<br/>* Clinical function: rare disease;<br/>* Clinical function: population health;<br/>* Promotion of and supporting and leading where relevant science, research and / or innovation;<br/>* Transformation and Service Improvement;<br/>* People – workforce, education and training; and<br/>* Data and digital<br/>The Commissioner intends to award contracts following the Most Suitable Process to 7 providers which are existing providers. This is an expansion of existing services which, under PSR, constitutes a new service.<br/>The approximate lifetime value of the contract for all Lots is £5,175,000,000.<br/>The services will start on 1st April 2026 and the initial period will run until 31st March 3034 with an option to extend for up to a further 2 years (of 2 x 12 month periods).<br/>Please note that the figure included in the 'Awarded Value' section of this part of the notice is the total approximate lifetime value of all Lots of the NHS Genomic Medicine Service contract. For the avoidance of doubt, this is not the approximate lifetime value for each Lot. The approximate lifetime value for each Lot shall be included within the confirmation of contract award notice (which shall be issued once contracts have been signed).

Options

Description
Option to extend for up to a further 2 years (of 2 x 12 month periods) following the initial 8 year contract period

Award criteria

Criteria

Criterion 1
Name
Most suitable provider process with regard to the key Criteria
Type
cost
Description
100
Entry 3
Id
3
Title
Lot 3 – NHS Central and South GMS
Status
cancelled
Has Options
Yes
Description
Pursuant to the NHS GMS contracts, providers are to provide the following functions:<br/>* Organisational leadership, governance and partnership arrangements;<br/>* Delivery of genomic testing outlined in the National Genomic Test Directory (NGTD);<br/>* Laboratory operating model;<br/>* Clinical function: cancer genomics;<br/>* Clinical function: rare disease;<br/>* Clinical function: population health;<br/>* Promotion of and supporting and leading where relevant science, research and / or innovation;<br/>* Transformation and Service Improvement;<br/>* People – workforce, education and training; and<br/>* Data and digital<br/>The Commissioner intends to award contracts following the Most Suitable Process to 7 providers which are existing providers. This is an expansion of existing services which, under PSR, constitutes a new service.<br/>The approximate lifetime value of the contract for all Lots is £5,175,000,000.<br/>The services will start on 1st April 2026 and the initial period will run until 31st March 3034 with an option to extend for up to a further 2 years (of 2 x 12 month periods).<br/>Please note that the figure included in the 'Awarded Value' section of this part of the notice is the total approximate lifetime value of all Lots of the NHS Genomic Medicine Service contract. For the avoidance of doubt, this is not the approximate lifetime value for each Lot. The approximate lifetime value for each Lot shall be included within the confirmation of contract award notice (which shall be issued once contracts have been signed).

Options

Description
Option to extend for up to a further 2 years (of 2 x 12 month periods) following the initial 8 year contract period

Award criteria

Criteria

Criterion 1
Name
Most suitable provider process with regard to the key Criteria
Type
cost
Description
100
Entry 4
Id
4
Title
Lot 4 – NHS East GMS
Status
cancelled
Has Options
Yes
Description
Pursuant to the NHS GMS contracts, providers are to provide the following functions:<br/>* Organisational leadership, governance and partnership arrangements;<br/>* Delivery of genomic testing outlined in the National Genomic Test Directory (NGTD);<br/>* Laboratory operating model;<br/>* Clinical function: cancer genomics;<br/>* Clinical function: rare disease;<br/>* Clinical function: population health;<br/>* Promotion of and supporting and leading where relevant science, research and / or innovation;<br/>* Transformation and Service Improvement;<br/>* People – workforce, education and training; and<br/>* Data and digital<br/>The Commissioner intends to award contracts following the Most Suitable Process to 7 providers which are existing providers. This is an expansion of existing services which, under PSR, constitutes a new service.<br/>The approximate lifetime value of the contract for all Lots is £5,175,000,000.<br/>The services will start on 1st April 2026 and the initial period will run until 31st March 3034 with an option to extend for up to a further 2 years (of 2 x 12 month periods).<br/>Please note that the figure included in the 'Awarded Value' section of this part of the notice is the total approximate lifetime value of all Lots of the NHS Genomic Medicine Service contract. For the avoidance of doubt, this is not the approximate lifetime value for each Lot. The approximate lifetime value for each Lot shall be included within the confirmation of contract award notice (which shall be issued once contracts have been signed).

Options

Description
Option to extend for up to a further 2 years (of 2 x 12 month periods) following the initial 8 year contract period

Award criteria

Criteria

Criterion 1
Name
Most suitable provider process with regard to the key Criteria
Type
cost
Description
100
Entry 5
Id
5
Title
Lot 5 – NHS South-West GMS
Status
cancelled
Has Options
Yes
Description
Pursuant to the NHS GMS contracts, providers are to provide the following functions:<br/>* Organisational leadership, governance and partnership arrangements;<br/>* Delivery of genomic testing outlined in the National Genomic Test Directory (NGTD);<br/>* Laboratory operating model;<br/>* Clinical function: cancer genomics;<br/>* Clinical function: rare disease;<br/>* Clinical function: population health;<br/>* Promotion of and supporting and leading where relevant science, research and / or innovation;<br/>* Transformation and Service Improvement;<br/>* People – workforce, education and training; and<br/>* Data and digital<br/>The Commissioner intends to award contracts following the Most Suitable Process to 7 providers which are existing providers. This is an expansion of existing services which, under PSR, constitutes a new service.<br/>The approximate lifetime value of the contract for all Lots is £5,175,000,000.<br/>The services will start on 1st April 2026 and the initial period will run until 31st March 3034 with an option to extend for up to a further 2 years (of 2 x 12 month periods).<br/>Please note that the figure included in the 'Awarded Value' section of this part of the notice is the total approximate lifetime value of all Lots of the NHS Genomic Medicine Service contract. For the avoidance of doubt, this is not the approximate lifetime value for each Lot. The approximate lifetime value for each Lot shall be included within the confirmation of contract award notice (which shall be issued once contracts have been signed).

Options

Description
Option to extend for up to a further 2 years (of 2 x 12 month periods) following the initial 8 year contract period

Award criteria

Criteria

Criterion 1
Name
Most suitable provider process with regard to the key Criteria
Type
cost
Description
100
Entry 6
Id
6
Title
Lot 6 – NHS North Thames GMS
Status
cancelled
Has Options
Yes
Description
Pursuant to the NHS GMS contracts, providers are to provide the following functions:<br/>* Organisational leadership, governance and partnership arrangements;<br/>* Delivery of genomic testing outlined in the National Genomic Test Directory (NGTD);<br/>* Laboratory operating model;<br/>* Clinical function: cancer genomics;<br/>* Clinical function: rare disease;<br/>* Clinical function: population health;<br/>* Promotion of and supporting and leading where relevant science, research and / or innovation;<br/>* Transformation and Service Improvement;<br/>* People – workforce, education and training; and<br/>* Data and digital<br/>The Commissioner intends to award contracts following the Most Suitable Process to 7 providers which are existing providers. This is an expansion of existing services which, under PSR, constitutes a new service.<br/>The approximate lifetime value of the contract for all Lots is £5,175,000,000.<br/>The services will start on 1st April 2026 and the initial period will run until 31st March 3034 with an option to extend for up to a further 2 years (of 2 x 12 month periods).<br/>Please note that the figure included in the 'Awarded Value' section of this part of the notice is the total approximate lifetime value of all Lots of the NHS Genomic Medicine Service contract. For the avoidance of doubt, this is not the approximate lifetime value for each Lot. The approximate lifetime value for each Lot shall be included within the confirmation of contract award notice (which shall be issued once contracts have been signed).

Options

Description
Option to extend for up to a further 2 years (of 2 x 12 month periods) following the initial 8 year contract period

Award criteria

Criteria

Criterion 1
Name
Most suitable provider process with regard to the key Criteria
Type
cost
Description
100
Entry 7
Id
7
Title
Lot 7 – NHS South-East GMS
Status
cancelled
Has Options
Yes
Description
Pursuant to the NHS GMS contracts, providers are to provide the following functions:<br/>* Organisational leadership, governance and partnership arrangements;<br/>* Delivery of genomic testing outlined in the National Genomic Test Directory (NGTD);<br/>* Laboratory operating model;<br/>* Clinical function: cancer genomics;<br/>* Clinical function: rare disease;<br/>* Clinical function: population health;<br/>* Promotion of and supporting and leading where relevant science, research and / or innovation;<br/>* Transformation and Service Improvement;<br/>* People – workforce, education and training; and<br/>* Data and digital<br/>The Commissioner intends to award contracts following the Most Suitable Process to 7 providers which are existing providers. This is an expansion of existing services which, under PSR, constitutes a new service.<br/>The approximate lifetime value of the contract for all Lots is £5,175,000,000.<br/>The services will start on 1st April 2026 and the initial period will run until 31st March 3034 with an option to extend for up to a further 2 years (of 2 x 12 month periods).<br/>Please note that the figure included in the 'Awarded Value' section of this part of the notice is the total approximate lifetime value of all Lots of the NHS Genomic Medicine Service contract. For the avoidance of doubt, this is not the approximate lifetime value for each Lot. The approximate lifetime value for each Lot shall be included within the confirmation of contract award notice (which shall be issued once contracts have been signed).

Options

Description
Option to extend for up to a further 2 years (of 2 x 12 month periods) following the initial 8 year contract period

Award criteria

Criteria

Criterion 1
Name
Most suitable provider process with regard to the key Criteria
Type
cost
Description
100

Items and delivery

Item 1
Id
1
Related Lot
1

Delivery locations

Entry 1
Region
UKD
Entry 2
Region
UKD

Additional Classifications

Entry 1
Id
85100000
Scheme
CPV
Description
Health services
Item 2
Id
2
Related Lot
2

Delivery locations

Entry 1
Region
UKC
Entry 2
Region
UKC

Additional Classifications

Entry 1
Id
85100000
Scheme
CPV
Description
Health services
Item 3
Id
3
Related Lot
3

Delivery locations

Entry 1
Region
UKF
Entry 2
Region
UKG

Additional Classifications

Entry 1
Id
85100000
Scheme
CPV
Description
Health services
Item 4
Id
4
Related Lot
4

Delivery locations

Entry 1
Region
UKH
Entry 2
Region
UKH

Additional Classifications

Entry 1
Id
85100000
Scheme
CPV
Description
Health services
Item 5
Id
5
Related Lot
5

Delivery locations

Entry 1
Region
UKK
Entry 2
Region
UKK

Additional Classifications

Entry 1
Id
85100000
Scheme
CPV
Description
Health services
Item 6
Id
6
Related Lot
6

Delivery locations

Entry 1
Region
UKI
Entry 2
Region
UKI

Additional Classifications

Entry 1
Id
85100000
Scheme
CPV
Description
Health services
Item 7
Id
7
Related Lot
7

Delivery locations

Entry 1
Region
UKJ
Entry 2
Region
UKJ

Additional Classifications

Entry 1
Id
85100000
Scheme
CPV
Description
Health services

Buyer, suppliers and contacts

Organisation 1
Id
GB-FTS-118033
Name
NHS England

Roles

buyer

Address

Region
UKE
Locality
Leeds
Postal Code
LS1 4AP
Country Name
United Kingdom
Street Address
7&8 Wellington Place

Details

Classifications

Entry 1
Id
BODY_PUBLIC
Scheme
TED_CA_TYPE
Description
Body governed by public law
Entry 2
Id
07
Scheme
COFOG
Description
Health

Identifier

Legal Name
NHS England

Contact

Name
Anna Salt
Organisation 2
Id
GB-FTS-18796
Name
Manchester University NHS Foundation Trust

Roles

supplier

Address

Region
UKD3
Locality
Manchester
Country Name
United Kingdom

Details

Scale
large

Identifier

Legal Name
Manchester University NHS Foundation Trust
Organisation 3
Id
GB-FTS-78899
Name
The Newcastle upon Tyne Hospitals NHS Foundation Trust

Roles

supplier

Address

Region
UKC2
Locality
Newcastle
Country Name
United Kingdom

Details

Scale
large

Identifier

Legal Name
The Newcastle upon Tyne Hospitals NHS Foundation Trust
Organisation 4
Id
GB-FTS-1009
Name
Birmingham Women’s and Children’s NHS Foundation Trust

Roles

supplier

Address

Region
UKG3
Locality
Birmingham
Country Name
United Kingdom

Details

Scale
large

Identifier

Legal Name
Birmingham Women’s and Children’s NHS Foundation Trust
Organisation 5
Id
GB-FTS-6625
Name
Cambridge University Hospitals NHS Foundation Trust

Roles

supplier

Address

Region
UKH1
Locality
Cambridge
Country Name
United Kingdom

Details

Scale
large

Identifier

Legal Name
Cambridge University Hospitals NHS Foundation Trust
Organisation 6
Id
GB-FTS-12898
Name
North Bristol NHS Trust

Roles

supplier

Address

Region
UKK1
Locality
Bristol
Country Name
United Kingdom

Details

Scale
large

Identifier

Legal Name
North Bristol NHS Trust
Organisation 7
Id
GB-FTS-95413
Name
Great Ormond Street Hospital for Children NHS Foundation Trust

Roles

supplier

Address

Region
UKI3
Locality
London
Country Name
United Kingdom

Details

Scale
large

Identifier

Legal Name
Great Ormond Street Hospital for Children NHS Foundation Trust
Organisation 8
Id
GB-FTS-21063
Name
Guy's and St Thomas' NHS Foundation Trust

Roles

supplier

Address

Region
UKI3
Locality
London
Country Name
United Kingdom

Details

Scale
large

Identifier

Legal Name
Guy's and St Thomas' NHS Foundation Trust
Organisation 9
Id
GB-FTS-141301
Name
NHS Arden and Greater East Midlands Commissioning Support Unit

Roles

reviewBody

Address

Locality
Derby
Postal Code
DE1 3QT
Country Name
United Kingdom
Street Address
Cardinal Square, 10 Nottingham Road

Details

Identifier

Legal Name
NHS Arden and Greater East Midlands Commissioning Support Unit

Award information

Award 1
Id
067976-2025-1
Title
Lot 1 - NHS North-West GMS
Status
active

Suppliers

Supplier 1
Id
GB-FTS-18796
Name
Manchester University NHS Foundation Trust

Related lots

1
Award 2
Id
067976-2025-2
Title
Lot 2 - NHS North-East and Yorkshire GMS
Status
active

Suppliers

Supplier 1
Id
GB-FTS-78899
Name
The Newcastle upon Tyne Hospitals NHS Foundation Trust

Related lots

2
Award 3
Id
067976-2025-3
Title
Lot 3 NHS Central and South GMS
Status
active

Suppliers

Supplier 1
Id
GB-FTS-1009
Name
Birmingham Women’s and Children’s NHS Foundation Trust

Related lots

3
Award 4
Id
067976-2025-4
Title
Lot 4 NHS East GMS
Status
active

Suppliers

Supplier 1
Id
GB-FTS-6625
Name
Cambridge University Hospitals NHS Foundation Trust

Related lots

4
Award 5
Id
067976-2025-5
Title
Lot 5 NHS South-West GMS
Status
active

Suppliers

Supplier 1
Id
GB-FTS-12898
Name
North Bristol NHS Trust

Related lots

5
Award 6
Id
067976-2025-6
Title
Lot 6 NHS North Thames GMS
Status
active

Suppliers

Supplier 1
Id
GB-FTS-95413
Name
Great Ormond Street Hospital for Children NHS Foundation Trust

Related lots

6
Award 7
Id
067976-2025-7
Title
Lot 7 NHS South-East GMS
Status
active

Suppliers

Supplier 1
Id
GB-FTS-21063
Name
Guy's and St Thomas' NHS Foundation Trust

Related lots

7

Contracts and changes

Entry 1
Id
067976-2025-1
Title
Lot 1 - NHS North-West GMS
Status
active
Award ID
067976-2025-1
Date Signed
21 Oct 2025, 00:00

Value

Amount
5,175,000,000
Currency
GBP
Entry 2
Id
067976-2025-2
Title
Lot 2 - NHS North-East and Yorkshire GMS
Status
active
Award ID
067976-2025-2
Date Signed
21 Oct 2025, 00:00

Value

Amount
5,175,000,000
Currency
GBP
Entry 3
Id
067976-2025-3
Title
Lot 3 NHS Central and South GMS
Status
active
Award ID
067976-2025-3
Date Signed
21 Oct 2025, 00:00

Value

Amount
5,175,000,000
Currency
GBP
Entry 4
Id
067976-2025-4
Title
Lot 4 NHS East GMS
Status
active
Award ID
067976-2025-4
Date Signed
21 Oct 2025, 00:00

Value

Amount
5,175,000,000
Currency
GBP
Entry 5
Id
067976-2025-5
Title
Lot 5 NHS South-West GMS
Status
active
Award ID
067976-2025-5
Date Signed
21 Oct 2025, 00:00

Value

Amount
5,175,000,000
Currency
GBP
Entry 6
Id
067976-2025-6
Title
Lot 6 NHS North Thames GMS
Status
active
Award ID
067976-2025-6
Date Signed
21 Oct 2025, 00:00

Value

Amount
5,175,000,000
Currency
GBP
Entry 7
Id
067976-2025-7
Title
Lot 7 NHS South-East GMS
Status
active
Award ID
067976-2025-7
Date Signed
21 Oct 2025, 00:00

Value

Amount
5,175,000,000
Currency
GBP

Recorded locations

  • Buyer location · Leeds · UKE · LS1 4AP · United Kingdom
  • Delivery location · UKC
  • Delivery location · UKD
  • Delivery location · UKF
  • Delivery location · UKG
  • Delivery location · UKH
  • Delivery location · UKI
  • Delivery location · UKJ
  • Delivery location · UKK

Notice and amendment history

1 published notice version reviewed by ProcuraAxis.

1 VERSION
  1. ocds-h6vhtk-0565e9-2025-10-23T17:00:36+01:00compiled ·